Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Mylan N.V. Ordinary Shares Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 43.88||$ 75.26|
|Low||$ 42.455||$ 37.59|
The current last sale of $42.60 is 13.33% Higher thanthe 52 week low.
ETFs with MYL as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|4.14%||SPDR S&P Pharmaceuticals ETF (XPH)||-11.31 (-20.76%)|
|4.08%||iShares Nasdaq Biotechnology Index Fund (IBB)||-56.45 (-16.90%)|
|3.81%||iShares U.S. Pharmaceutical ETF (IHE)||-19.73 (-12.06%)|
|0%||Proshares UltraPro Nasdaq Biotechnology (UBIO)||-28.38 (-50.29%)|
|0%||Direxion iBillionaire Index ETF (IBLN)||-0.15 (-0.61%)|
Company Description (as filed with the SEC)
Mylan N.V., along with its subsidiaries (collectively, the "Company," "Mylan," "our" or "we"), is a leading global pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. Mylan is committed to setting new standards in healthcare by creating better health for a better world, and our mission is to provide the world's 7 billion people access to high quality medicine. To do so, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. Mylan offers one of the industry's broadest product portfolios, including more than 1,400 marketed products, to customers in approximately 165 countries and territories. ... More ...
Where does MYL fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$4.3|
|Quarterly EPS Est:||0.75|